{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:21:15Z","timestamp":1758637275788},"reference-count":132,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.cld.2009.02.011","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T04:33:16Z","timestamp":1242189196000},"page":"295-316","source":"Crossref","is-referenced-by-count":4,"title":["Management of Autoimmune and Cholestatic Liver Disorders"],"prefix":"10.1016","volume":"13","author":[{"given":"Karen L.","family":"Krok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago J.","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2009.02.011_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib3","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.3748\/wjg.14.3301","article-title":"Clinical features and management of autoimmune hepatitis","volume":"14","author":"Krawitt","year":"2008","journal-title":"World J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MCC.0b013e3282f6a420","article-title":"Etiologies of acute liver failure","volume":"14","author":"Lee","year":"2008","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cld.2009.02.011_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0168-8278(99)80342-0","article-title":"Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis","volume":"31","author":"Kanzler","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1572-0241.2001.03707.x","article-title":"Understanding the pathogenesis of autoimmune hepatitis","volume":"96","author":"Czaja","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib7","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/0016-5085(93)90160-E","article-title":"Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib8","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3748\/wjg.14.3290","article-title":"Autoimmune liver diseases","volume":"14","author":"Invernizzi","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/hep.22438","article-title":"The challenge of diagnosing autoimmune hepatitis: less is more","volume":"48","author":"Choi","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.gtc.2008.02.002","article-title":"Diagnosis and treatment of autoimmune hepatitis","volume":"37","author":"Luxon","year":"2008","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cld.2009.02.011_bib11","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib12","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.3748\/wjg.14.3292","article-title":"Historical reflections on autoimmune hepatitis","volume":"14","author":"Mackay","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S1665-2681(19)31899-X","article-title":"The medical treatment for autoimmune hepatitis through corticosteroid to new immunosuppressive agents: a concise review","volume":"6","author":"Soloway","year":"2007","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib14","first-page":"57","article-title":"Treatment of patients with severe autoimmune hepatitis","volume":"54","author":"Larsen","year":"2008","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.cld.2009.02.011_bib15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/MEG.0b013e3282f493c5","article-title":"Minocycline hepatitis","volume":"20","author":"Ford","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2009.02.011_bib16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S1590-8658(07)80006-5","article-title":"Hepatitis C and autoreactivity","volume":"39","author":"Bianchi","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2009.02.011_bib17","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1590-8658(07)80005-3","article-title":"HCV-related autoimmune and neoplastic disorders: the HCV syndrome","volume":"39","author":"Ferri","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cld.2009.02.011_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/BF01316792","article-title":"Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis","volume":"38","author":"Fried","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2009.02.011_bib19","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1568-9972(03)00036-3","article-title":"Autoimmunity and hepatitis C","volume":"2","author":"Strassburg","year":"2003","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.cld.2009.02.011_bib20","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","author":"Ayata","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib23","first-page":"1999","article-title":"Liver transplantation for autoimmune hepatitis: rejection and recurrence","volume":"31","author":"Narumi","year":"1955","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2009.02.011_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2009.02.011_bib25","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/S0041-1345(02)03570-4","article-title":"Autoimmune hepatitis following liver transplantation: relationship to recurrent disease and steroid weaning","volume":"34","author":"Heffron","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.cld.2009.02.011_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","author":"Reich","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib28","first-page":"3053","article-title":"Liver transplantation in autoimmune liver disease\u2014selection of patients","volume":"46","author":"Tillmann","year":"1999","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib29","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib30","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(05)80139-4","article-title":"Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years","volume":"20","author":"Mahl","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib31","first-page":"377","article-title":"The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease?","volume":"75","author":"Myszor","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1136\/gut.2003.023937","article-title":"Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort","volume":"53","author":"Prince","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.cld.2009.02.011_bib33","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib34","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib35","doi-asserted-by":"crossref","first-page":"7317","DOI":"10.1073\/pnas.85.19.7317","article-title":"Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase","volume":"85","author":"Coppel","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cld.2009.02.011_bib36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0140-6736(87)91610-2","article-title":"Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?","volume":"1","author":"Poupon","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2009.02.011_bib37","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1572-0241.2004.04047.x","article-title":"Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis","volume":"99","author":"Combes","year":"2004","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib38","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.1840190512","article-title":"The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis","volume":"19","author":"Heathcote","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib39","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/0016-5085(94)90021-3","article-title":"Ursodeoxycholic acid in the treatment of primary biliary cirrhosis","volume":"106","author":"Lindor","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0168-8278(00)80216-0","article-title":"Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver","volume":"32","author":"Pares","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1056\/NEJM199105303242204","article-title":"A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group","volume":"324","author":"Poupon","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib42","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1111\/j.1572-0241.2007.01235.x","article-title":"Ursodeoxycholic acid for patients with primary biliary cirrhosis: an updated systematic review and meta-analysis of randomized clinical trials using Bayesian approach as sensitivity analyses","volume":"102","author":"Gong","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib43","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(98)11293-X","article-title":"Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis","volume":"354","author":"Goulis","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2009.02.011_bib44","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/j.1572-0241.2006.00634.x","article-title":"Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials","volume":"101","author":"Shi","year":"2006","journal-title":"Am J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0168-8278(03)00192-2","article-title":"Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis","volume":"39","author":"Poupon","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib46","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1053\/j.gastro.2004.11.009","article-title":"The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis","volume":"128","author":"Corpechot","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib47","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/72.12.1137","article-title":"Ursodeoxycholic acid delays the onset of esophageal varices in primary biliary cirrhosis","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cld.2009.02.011_bib48","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/0016-5085(85)90213-6","article-title":"Beneficial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis. Final results of an international trial","volume":"89","author":"Christensen","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib49","article-title":"Azathioprine for primary biliary cirrhosis","volume":"3","author":"Gong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2009.02.011_bib50","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/0168-8278(92)90065-W","article-title":"A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results","volume":"15","author":"Mitchison","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0016-5085(93)90422-9","article-title":"Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial","volume":"104","author":"Lombard","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib52","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/0016-5085(88)90373-3","article-title":"Pilot study of cyclosporin A in patients with symptomatic primary biliary cirrhosis","volume":"95","author":"Minuk","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM199005173222003","article-title":"A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis","volume":"322","author":"Wiesner","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib54","article-title":"Cyclosporin A for primary biliary cirrhosis","volume":"3","author":"Gong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2009.02.011_bib55","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0016-5085(88)90300-9","article-title":"Evaluation of colchicine therapy in primary biliary cirrhosis","volume":"95","author":"Bodenheimer","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib56","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM198612043152304","article-title":"A prospective trial of colchicine for primary biliary cirrhosis","volume":"315","author":"Kaplan","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8278(87)80053-3","article-title":"A controlled trial of colchicine in primary biliary cirrhosis. Trial design and preliminary report","volume":"5","author":"Warnes","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib58","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/hep.1840140607","article-title":"Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy","volume":"14","author":"Zifroni","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib59","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1572-0241.2005.41522.x","article-title":"Colchicine for primary biliary cirrhosis: a Cochrane Hepato-Biliary Group systematic review of randomized clinical trials","volume":"100","author":"Gong","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib60","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0016-5085(95)90696-7","article-title":"A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid","volume":"108","author":"Vuoristo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib61","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2036.2006.03048.x","article-title":"Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy","volume":"24","author":"Babatin","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2009.02.011_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1572-0241.2003.07173.x","article-title":"Methotrexate therapy for primary biliary cirrhosis","volume":"98","author":"Bach","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/gast.1999.0029900395","article-title":"Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol","volume":"117","author":"Bonis","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0168-8278(05)80004-2","article-title":"Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone","volume":"18","author":"Buscher","year":"1993","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/gast.1999.0029900400","article-title":"Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial","volume":"117","author":"Hendrickse","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib66","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2009.02.011_bib67","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)90085-Y","article-title":"Treatment of primary biliary cirrhosis with low-dose weekly methotrexate","volume":"101","author":"Kaplan","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib68","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0016-5085(99)70403-8","article-title":"A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis","volume":"117","author":"Kaplan","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib69","first-page":"1158","article-title":"The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study","volume":"22","author":"Lindor","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib70","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.20897","article-title":"Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis","volume":"42","author":"Combes","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib71","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.20103","article-title":"A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results","volume":"39","author":"Kaplan","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib72","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1136\/gut.19.11.1022","article-title":"Hepatocellular carcinoma in Great Britain: influence of age, sex, HBsAg status, and aetiology of underlying cirrhosis","volume":"19","author":"Johnson","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.cld.2009.02.011_bib73","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MEG.0b013e3282f163ed","article-title":"Risk of hepatocellular carcinoma and extrahepatic malignancies in primary biliary cirrhosis","volume":"20","author":"Deutsch","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib74","first-page":"676","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis","volume":"92","author":"Turissini","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib75","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.510260508","article-title":"Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes","volume":"26","author":"Jones","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib76","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1053\/jhep.2002.33157","article-title":"Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis","volume":"35","author":"Shibuya","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cgh.2006.09.031","article-title":"Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"5","author":"Suzuki","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib78","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/hep.22458","article-title":"Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis","volume":"48","author":"Silveira","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib79","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cgh.2007.07.015","article-title":"Transplantation trends in primary biliary cirrhosis","volume":"5","author":"Lee","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","article-title":"Prognosis in primary biliary cirrhosis: model for decision making","volume":"10","author":"Dickson","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","author":"Liermann Garcia","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib82","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/lt.20123","article-title":"Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation","volume":"10","author":"Neuberger","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2009.02.011_bib83","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1136\/bmj.1.5325.216","article-title":"Treatment of pruritus of obstructive jaundice with cholestyramine","volume":"1","author":"Datta","year":"1963","journal-title":"Br Med J"},{"key":"10.1016\/j.cld.2009.02.011_bib84","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0016-5085(19)31870-0","article-title":"Elevations in skin tissue levels of bile acids in human cholestasis: relation to serum levels and to pruritus","volume":"73","author":"Ghent","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib85","first-page":"15","article-title":"Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis","volume":"85","author":"Matsuzaki","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib86","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","article-title":"Sertraline as a first-line treatment for cholestatic pruritus","volume":"45","author":"Mayo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib87","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1111\/j.1572-0241.2003.08662.x","article-title":"Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis","volume":"98","author":"Browning","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib88","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/0016-5085(92)90335-V","article-title":"Effects of long-term rifampicin administration in primary biliary cirrhosis","volume":"102","author":"Bachs","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib89","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/0016-5085(88)90442-8","article-title":"Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial","volume":"94","author":"Ghent","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib90","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1136\/bmj.297.6662.1501","article-title":"Opioid peptides and primary biliary cirrhosis","volume":"297","author":"Thornton","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2009.02.011_bib91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7326\/0003-4819-123-3-199508010-00001","article-title":"Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial","volume":"123","author":"Bergasa","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2009.02.011_bib92","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/gast.1997.v113.pm9322521","article-title":"Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study","volume":"113","author":"Wolfhagen","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib93","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/gut.26.3.291","article-title":"Role of plasmapheresis in primary biliary cirrhosis","volume":"26","author":"Cohen","year":"1985","journal-title":"Gut"},{"key":"10.1016\/j.cld.2009.02.011_bib94","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199405123301903","article-title":"Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group","volume":"330","author":"Poupon","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib95","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2133.1987.tb05825.x","article-title":"A combination of phototherapy and cholestyramine for the relief of pruritus in primary biliary cirrhosis","volume":"116","author":"Cerio","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cld.2009.02.011_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00442746","article-title":"Effects of phenobarbital on biliary lipid metabolism in children with chronic intrahepatic cholestasis","volume":"143","author":"Becker","year":"1984","journal-title":"Eur J\u00a0Pediatr"},{"key":"10.1016\/j.cld.2009.02.011_bib97","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/bjo.69.11.832","article-title":"Patterns of lacrimal dysfunction in primary biliary cirrhosis","volume":"69","author":"Giovannini","year":"1985","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.cld.2009.02.011_bib98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/PL00009532","article-title":"Primary biliary cirrhosis, sicca complex, and dysphagia","volume":"12","author":"Mang","year":"1997","journal-title":"Dysphagia"},{"key":"10.1016\/j.cld.2009.02.011_bib99","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0002-9343(71)90218-X","article-title":"Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome","volume":"50","author":"Reynolds","year":"1971","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib100","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0168-8278(87)80035-1","article-title":"Portal hypertension in primary biliary cirrhosis. Relationship with histological features","volume":"5","author":"Navasa","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib101","first-page":"467","article-title":"Variceal bleeding is associated with reduced risk of severe cholestasis in primary biliary cirrhosis","volume":"71","author":"Thornton","year":"1989","journal-title":"Q J Med"},{"key":"10.1016\/j.cld.2009.02.011_bib102","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep.1840200617","article-title":"Effect of distal splenorenal shunt on survival of patients with primary biliary cirrhosis","volume":"20","author":"Boyer","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib103","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0016-5085(00)70423-9","article-title":"Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis","volume":"118","author":"Springer","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib104","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0168-8278(01)00144-1","article-title":"Bone disease in primary biliary cirrhosis: independent indicators and rate of progression","volume":"35","author":"Menon","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib105","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-103-6-855","article-title":"Bone loss and reduced osteoblast function in primary biliary cirrhosis","volume":"103","author":"Hodgson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2009.02.011_bib106","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1172\/JCI117959","article-title":"Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice","volume":"95","author":"Janes","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cld.2009.02.011_bib107","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Guanabens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","article-title":"Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A\u00a0prospective, controlled pilot study","volume":"26","author":"Wolfhagen","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib109","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib110","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0270-9139(94)90098-1","article-title":"Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis","volume":"20","author":"Camisasca","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib111","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0016-5085(82)80291-6","article-title":"Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment","volume":"83","author":"Matloff","year":"1982","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib112","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D\u00a0status","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.cld.2009.02.011_bib113","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/hep.1840050522","article-title":"Pathogenesis of steatorrhea in primary biliary cirrhosis","volume":"5","author":"Lanspa","year":"1985","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib114","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/hep.1840090403","article-title":"Vitamin E deficiency in primary biliary cirrhosis: gastrointestinal malabsorption, frequency and relationship to other lipid-soluble vitamins","volume":"9","author":"Munoz","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib115","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1111\/j.1572-0241.2001.04134.x","article-title":"Fat-soluble vitamin levels in patients with primary biliary cirrhosis","volume":"96","author":"Phillips","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib116","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF01311724","article-title":"Increased incidence of hypothyroidism in primary biliary cirrhosis","volume":"28","author":"Elta","year":"1983","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2009.02.011_bib117","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11894-006-0067-8","article-title":"Primary sclerosing cholangitis: diagnosis and management","volume":"8","author":"Charatcharoenwitthaya","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cld.2009.02.011_bib118","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2036.2005.02407.x","article-title":"Review article: current management of primary sclerosing cholangitis","volume":"21","author":"Cullen","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2009.02.011_bib119","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1089-3261(03)00127-2","article-title":"Primary sclerosing cholangitis","volume":"8","author":"Mendes","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2009.02.011_bib120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1155\/2008\/824168","article-title":"Primary sclerosing cholangitis","volume":"22","author":"Silveira","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib121","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/lt.21456","article-title":"Current diagnosis and management of primary sclerosing cholangitis","volume":"14","author":"Tischendorf","year":"2008","journal-title":"Liver Transpl"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2009.02.011_bib122","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis\u2013aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weismuller","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2009.02.011_bib123","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib124","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib125","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"10.1016\/j.cld.2009.02.011_bib126","first-page":"378A","article-title":"Randomized, double-blind, controlled trial of high-dose ursodeoxycholic acid (UDCA) for primary sclerosing cholangitis","volume":"48","author":"Lindor","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2009.02.011_bib127","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.cld.2009.02.011_bib128","first-page":"221","article-title":"Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study","volume":"55","author":"Mishima","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.cld.2009.02.011_bib129","first-page":"79","article-title":"Diagnostic and therapeutic questions in overlap syndromes of autoimmune hepatitis","volume":"53","author":"Premoli","year":"2007","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1016\/j.cld.2009.02.011_bib130","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2009.02.011_bib131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1089-3261(05)70098-2","article-title":"Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis","volume":"4","author":"Sherlock","year":"2000","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2009.02.011_bib132","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326109000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T23:53:48Z","timestamp":1589759628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326109000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S1089326109000130"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2009.02.011","relation":{},"ISSN":["1089-3261"],"issn-type":[{"type":"print","value":"1089-3261"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}